The role of enterobacteriaceae in gut microbiota dysbiosis in inflammatory bowel diseases

Research output: Contribution to journalReview articlepeer-review


Inflammatory bowel diseases (IBDs) are a group of chronic gastrointestinal inflammatory diseases with unknown etiology. There is a combination of well documented factors in their pathogen-esis, including intestinal microbiota dysbiosis. The symbiotic microbiota plays important functions in the host, and the loss of beneficial microbes could favor the expansion of microbial pathobionts. In particular, the bloom of potentially harmful Proteobacteria, especially Enterobacteriaceae, has been described as enhancing the inflammatory response, as observed in IBDs. Herein, we seek to investigate the contribution of Enterobacteriaceae to IBD pathogenesis whilst considering the continuous expansion of the literature and data. Despite the mechanism of their expansion still remaining unclear, their expansion could be correlated with the increase in nitrate and oxygen levels in the inflamed gut and with the bile acid dysmetabolism described in IBD patients. Furthermore, in several Enterobacteriaceae studies conducted at a species level, it has been suggested that some adherent-invasive Escherichia coli (AIEC) play an important role in IBD pathogenesis. Overall, this review highlights the pivotal role played by Enterobacteriaceae in gut dysbiosis associated with IBD pathogenesis and progression.

Original languageEnglish
Article number697
Issue number4
Publication statusPublished - Apr 2021


  • Enterobacteriaceae
  • Inflammation
  • Inflammatory bowel diseases (IBDs)
  • Microbiota

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)
  • Virology


Dive into the research topics of 'The role of enterobacteriaceae in gut microbiota dysbiosis in inflammatory bowel diseases'. Together they form a unique fingerprint.

Cite this